4.5 Review

Lipid Storage Myopathy

期刊

出版社

SPRINGER
DOI: 10.1007/s11910-010-0154-y

关键词

Lipid storage myopathy; Primary carnitine deficiency; Multiple acyl-coenzyme A dehydrogenase deficiency; Neutrolipid storage disease

资金

  1. KAKENHI
  2. Health and Labour Sciences Research Grants
  3. Research Grants for Nervous and Mental Disorders
  4. National Institute of Biomedical Innovation (NIBIO)
  5. Neuromuscular Foundation
  6. Japan Foundation for Neuroscience and Mental Health/Genzyme Japan
  7. Japanese Health Sciences Foundation

向作者/读者索取更多资源

Lipid storage myopathy (LSM) is pathologically characterized by prominent lipid accumulation in muscle fibers due to lipid dysmetabolism. Although extensive molecular studies have been performed, there are only four types of genetically diagnosable LSMs: primary carnitine deficiency (PCD), multiple acyl-coenzyme A dehydrogenase deficiency (MADD), neutral lipid storage disease with ichthyosis, and neutral lipid storage disease with myopathy. Making an accurate diagnosis, by specific laboratory tests including genetic analyses, is important for LSM as some of the patients are treatable: individuals with PCD show dramatic improvement with high-dose oral L-carnitine supplementation and increasing evidence indicates that MADD due to ETFDH mutations is riboflavin responsive.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据